SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-025338
Filing Date
2024-06-26
Accepted
2024-06-26 21:30:07
Documents
1
Period of Report
2024-06-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3998
  Complete submission text file 0001493152-24-025338.txt   5335
Mailing Address
Business Address
GOLDSTEIN DOV A MD (Reporting) CIK: 0001120478 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-40237 | Film No.: 241075089

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)